ESMO 2021 | Highlights from ESMO 2021: mucosal and acral melanoma
Ines Pires Da Silva • 28 Sep 2021
Ines Pires da Silva, MD, PhD, Melanoma Institute Australia and The University of Sydney, Sydney, Australia, outlines two large studies on mucosal and acral melanoma that were presented at ESMO 2021. This interview took place at the European Society for Medical Oncology (ESMO) 2021 congress.
Disclosures
Dr da Silva reports travel support by BMS and MSD, and speaker fee by Roche, BMS, MSD and Novartis.
